(Q33929563)

30 July 2017

1 reference

title

Risk-benefit ratio of angiotensin antagonists versus ACE inhibitors in end-stage renal disease (English)

1 reference

30 July 2017

D A Sica

1

1 reference

30 July 2017

T W Gehr

series ordinal

2

1 reference

30 July 2017

A Fernandez

series ordinal

3

1 reference

30 July 2017

publication date

1 May 2000

1 reference

30 July 2017

1 reference

30 July 2017

volume

22

1 reference

30 July 2017

issue

5

1 reference

30 July 2017

page(s)

350-360

1 reference

Pharmacokinetics of enalapril in normal subjects and patients with renal impairment

30 July 2017

cites work

1 reference

https://api.crossref.org/works/10.2165%2F00002018-200022050-00003

Pharmacokinetics of quinapril and its active metabolite, quinaprilat, in patients on chronic hemodialysis

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00002018-200022050-00003

Renal failure, uncontrollable thirst, and hyperreninemia. Cessation of thirst with bilateral nephrectomy

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00002018-200022050-00003

Role of angiotensin II in the pathogenesis of hyperdipsia in chronic renal failure

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00002018-200022050-00003

Lack of efficacy of angiotensin-converting enzyme inhibitors in reducing interdialytic weight gain.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00002018-200022050-00003

Cough and angioneurotic edema associated with angiotensin-converting enzyme inhibitor therapy. A review of the literature and pathophysiology

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00002018-200022050-00003

Anaphylactoid reactions during hemodialysis and hemofiltration: role of associating AN69 membrane and angiotensin I-converting enzyme inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00002018-200022050-00003

Losartan versus ramipril in the treatment of postrenal transplant erythrocytosis

21 January 2018

1 reference

12 December 2020

Hypertension in the ESRD patient: pathophysiology, therapy, outcomes, and future directions

1 reference

12 December 2020

High dose enalapril impairs the response to erythropoietin treatment in haemodialysis patients

1 reference

12 December 2020

The pharmacokinetics of captopril and captopril disulfide conjugates in uraemic patients on maintenance dialysis: Comparison with patients with normal renal function

1 reference

12 December 2020

INTERFERENCE OF ANGIOTENSIN-CONVERTING ENZYME INHIBITORS ON ERYTHROPOIESIS IN KIDNEY TRANSPLANT RECIPIENTS

1 reference

12 December 2020

Controlling the epidemic of cardiovascular disease in chronic renal disease: what do we know? What do we need to learn? Where do we go from here? National Kidney Foundation Task Force on Cardiovascular Disease

1 reference

12 December 2020

Elimination kinetics of captopril in patients with renal failure

1 reference

12 December 2020

Anaphylactoid reactions during hemodialysis on AN69 membranes in patients receiving ACE inhibitors

1 reference

12 December 2020

A comparison of the effect of enalapril and metoprolol on renal function, potassium balance, lipid profile, cardiac function, exercise tolerance and quality of life in hypertensive dialysis patients

1 reference

12 December 2020

Ambulatory blood pressure monitoring in end-stage renal disease.

1 reference

12 December 2020

Disposition of enalapril and enalaprilat in renal insufficiency

1 reference

12 December 2020

Comparison of angiotensin-converting enzyme inhibition with angiotensin II receptor antagonism in the human forearm

1 reference

12 December 2020

Evaluation of the Losartan in Hemodialysis (ELHE) Study

1 reference

12 December 2020

On the epidemic of cardiovascular disease in patients with chronic renal disease and progressive renal failure: a first step to improve the outcomes

1 reference

12 December 2020

Valsartan, a new angiotensin II receptor antagonist: a double-blind study comparing the incidence of cough with lisinopril and hydrochlorothiazide

1 reference

12 December 2020

Body fluid spaces and blood pressure in hemodialysis patients during amelioration of anemia with erythropoietin

1 reference

12 December 2020

Angioedema associated with angiotensin II receptor antagonist losartan

1 reference

12 December 2020

Pharmacokinetics and protein binding of eprosartan in hemodialysis-dependent patients with end-stage renal disease.

1 reference

12 December 2020

Pharmacokinetics and protein binding of eprosartan in healthy volunteers and in patients with varying degrees of renal impairment.

1 reference

12 December 2020

Potential angiotensin-converting enzyme inhibitor-epoetin alfa interaction in patients receiving chronic hemodialysis.

1 reference

12 December 2020

Cough and angiotensin II receptor antagonists: cause or confounding?

1 reference

12 December 2020

Anaemia in dialysis patients as a side-effect of sartanes

1 reference

12 December 2020

Role of intrarenal endothelin in the generation and maintenance of hypertension

1 reference

12 December 2020

Anaphylactoid reactions in patients on hemodiafiltration with AN69 membranes whilst receiving ACE inhibitors

1 reference

12 December 2020

Participation of the renin-angiotensin system in the captopril-induced worsening of anemia in chronic hemodialysis patients

1 reference

12 December 2020

ACE inhibitor- versus angiotensin II blocker-induced cough and angioedema

1 reference

12 December 2020

Angiotensin-converting enzyme inhibitors but not angiotensin II AT 1 receptor antagonists affect erythropoiesis in patients with anemia of end-stage renal disease

1 reference

12 December 2020

Hypertension in chronic renal failure. An abnormal relation between sodium and the renin-angiotensin system.

1 reference

12 December 2020

Efficacy and tolerability of losartan in hypertensive patients with renal impairment. Collaborative Group

1 reference

12 December 2020

The effect of renal function on enalapril kinetics

1 reference

12 December 2020

Plasma renin and exchangeable sodium in the hypertension of chronic renal failure. The effect of bilateral nephrectomy

1 reference

12 December 2020

Angioedema induced by the angiotensin II blocker losartan

1 reference

12 December 2020

Trandolapril. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in essential hypertension

1 reference

12 December 2020

The pharmacokinetics of irbesartan in renal failure and maintenance hemodialysis

1 reference

12 December 2020

Effect of angiotensin-converting enzyme inhibitors on response to erythropoietin therapy in chronic dialysis patients

1 reference

12 December 2020

Pharmacokinetics of lisinopril, enalapril and enalaprilat in renal failure: effects of haemodialysis

1 reference

12 December 2020

Treatment of hypertension with lisinopril in end-stage renal failure

1 reference

12 December 2020

Pharmacokinetics of a new angiotensin-converting enzyme inhibitor, benazepril hydrochloride, in special populations

1 reference

12 December 2020

Cardiovascular disease in patients with end-stage renal failure

1 reference

12 December 2020

Influence of interdialytic weight gain on blood pressure in hemodialysis patients

1 reference

12 December 2020

Accupril- and Cozaar-induced angioedema in the same patient

1 reference

12 December 2020

Pharmacokinetics and pharmacodynamics of captopril in patients undergoing continuous ambulatory peritoneal dialysis

1 reference

12 December 2020

Angio-oedema in relation to treatment with angiotensin converting enzyme inhibitors

1 reference

12 December 2020

The effect of haemodialysis on the pharmacokinetics of perindoprilat after long-term perindopril

1 reference

12 December 2020

Effect of cilazapril on hyperdipsia in hemodialyzed patients.

1 reference

12 December 2020

Abnormal hemodynamics and elevated angiotensin II plasma levels in polydipsic patients on regular hemodialysis treatment

1 reference

12 December 2020

Ambulatory blood pressure monitoring in dialysis patients and estimation of mean interdialytic blood pressure.

1 reference

12 December 2020

1 reference

12 December 2020

Anaphylactoid reactions during hemodialysis in sheep are ACE inhibitor dose-dependent and mediated by bradykinin

1 reference

12 December 2020

High- versus low-dose ACE inhibition in chronic heart failure: a double-blind, placebo-controlled study of imidapril

1 reference

12 December 2020

Anaphylactoid reactions in hemodialysis patients treated with the AN69 dialyzer

1 reference

12 December 2020

Interrelation of the renin system and erythropoietin in rats

1 reference

12 December 2020

Bradykinin is a mediator of anaphylactoid reactions during hemodialysis with AN69 membranes

1 reference

12 December 2020

Enhanced cardiovascular pressor reactivity to norepinephrine in mild renal parenchymal disease

1 reference

12 December 2020

Angioneurotic edema attributed to the use of losartan

1 reference

12 December 2020

Captopril (SQ 14225) clearance during hemodialysis treatment.

1 reference

12 December 2020

Pharmacokinetics and pharmacodynamics of quinaprilat after low dose quinapril in patients with terminal renal failure

1 reference

12 December 2020

Endothelin-3 concentrations in human plasma: the increased concentrations in patients undergoing haemodialysis

1 reference

12 December 2020

Kinetics of angiotensin-converting enzyme inhibitors in renal failure

1 reference

12 December 2020

The pharmacokinetics of perindopril and its effects on serum angiotensin converting enzyme activity in hypertensive patients with chronic renal failure

1 reference

12 December 2020

Acute angiotensin-converting enzyme inhibition increases the plasma level of the natural stem cell regulator N-acetyl-seryl-aspartyl-lysyl-proline

1 reference

12 December 2020

Effects and tolerability of irbesartan versus enalapril in patients with severe hypertension. Irbesartan Multicenter Investigators

1 reference

12 December 2020

Worsening of anemia by angiotensin converting enzyme inhibitors and its prevention by antiestrogenic steroid in chronic hemodialysis patients

1 reference

12 December 2020

Hyperparathyroidism, platelet intracellular free calcium and hypertension in chronic renal failure

1 reference

12 December 2020

Anaphylactoid reactions associated with reuse of hollow-fiber hemodialyzers and ACE inhibitors

1 reference

12 December 2020

Losartan and renal transplantation

1 reference

12 December 2020

Angiotensin-converting enzyme inhibitor and anemia in a patient undergoing hemodialysis

1 reference

12 December 2020

The pharmacokinetics and pharmacodynamics of fosinopril in haemodialysis patients

1 reference

12 December 2020

Angiotensin-converting enzyme (ACE) inhibitors have been reported to induce or worsen anemia in patients on hemodialysis

1 reference

12 December 2020

Severe anaphylactoid reactions to cuprammonium cellulose hemodialyzers

1 reference

12 December 2020

Sympathetic overactivity in patients with chronic renal failure

1 reference

12 December 2020

Worsening of anemia induced by long-term use of captopril in hemodialysis patients

1 reference

12 December 2020

Fosinopril pharmacokinetics and pharmacodynamics in chronic ambulatory peritoneal dialysis patients

1 reference

12 December 2020

ACE inhibitor-induced angioedema. Incidence, prevention and management

1 reference

12 December 2020

Comparison of the Steady-State Pharmacokinetics of Fosinopril, Lisinopril and Enalapril in Patients with Chronic Renal Insufficiency

1 reference

12 December 2020

Kinetics, safety, and efficacy of ramipril after long-term administration in hemodialyzed patients

1 reference

12 December 2020

Angiotensin-converting enzyme inhibitors are associated with the need for increased recombinant human erythropoietin maintenance doses in hemodialysis patients. Risks of Cardiac Disease in Dialysis Patients Study Group

1 reference

12 December 2020

Accumulation of an endogenous inhibitor of nitric oxide synthesis in chronic renal failure

1 reference

12 December 2020

Genesis and control of hypertension in hemodialysis patients

1 reference

12 December 2020

Hypertension in patients with chronic renal disease

1 reference

12 December 2020

Controlled trial of enalapril in patients with chronic fluid overload undergoing dialysis

1 reference

12 December 2020

Effects of modulators of the renin-angiotensin-aldosterone system on cough. Losartan Cough Study Group.

1 reference

12 December 2020

10.2165/00002018-200022050-00003

Identifiers

DOI

1 reference

Dimensions Publication ID

30 July 2017

1049597555

0 references

1 reference